{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T01:03:35Z","timestamp":1794013415404,"version":"4.8.0"},"reference-count":362,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,27]],"date-time":"2022-05-27T00:00:00Z","timestamp":1653609600000},"content-version":"vor","delay-in-days":3799,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","fertstert.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Fertility and Sterility"],"published-print":{"date-parts":[[2012,1]]},"DOI":"10.1016\/j.fertnstert.2011.09.024","type":"journal-article","created":{"date-parts":[[2011,12,9]],"date-time":"2011-12-09T16:06:49Z","timestamp":1323446809000},"page":"28-38.e25","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1545,"title":["Consensus on women\u2019s health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE\/ASRM-Sponsored 3rd PCOS Consensus Workshop Group"],"prefix":"10.1016","volume":"97","author":[{"given":"Bart C.J.M.","family":"Fauser","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Basil C.","family":"Tarlatzis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert W.","family":"Rebar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard S.","family":"Legro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam H.","family":"Balen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger","family":"Lobo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrico","family":"Carmina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bulent O.","family":"Yildiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joop S.E.","family":"Laven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacky","family":"Boivin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felice","family":"Petraglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.N.","family":"Wijeyeratne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert J.","family":"Norman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Dunaif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Franks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A.","family":"Wild","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Dumesic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kurt","family":"Barnhart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.fertnstert.2011.09.024_bib1","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/humrep\/deh098","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)","volume":"19","year":"2004","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib2","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.fertnstert.2003.10.004","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome","volume":"81","year":"2004","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib3","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.fertnstert.2007.09.041","article-title":"Consensus on infertility treatment related to polycystic ovary syndrome","volume":"89","year":"2008","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib4","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1093\/humrep\/dem426","article-title":"Consensus on infertility treatment related to polycystic ovary syndrome","volume":"23","year":"2008","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib5","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1196\/annals.1429.005","article-title":"Polycystic ovary syndrome in adolescence","volume":"1135","author":"Blank","year":"2008","journal-title":"Ann NY Acad Sci"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib6","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/S1043-2760(98)00020-4","article-title":"Endocrine and metabolic abnormalities in adolescents with a PCOS-like condition: consequences for adult reproduction","volume":"9","author":"Apter","year":"1998","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib7","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1093\/humrep\/deh079","article-title":"Predictive value of menstrual cycle pattern, body mass index, hormone levels and polycystic ovaries at age 15 years for oligo-amenorrhoea at age 18 years","volume":"19","author":"van Hooff","year":"2004","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib8","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1203\/00006450-199512000-00024","article-title":"Longitudinal change of sonographic ovarian aspects and endocrine parameters in irregular cycles of adolescence","volume":"38","author":"Venturoli","year":"1995","journal-title":"Pediatr Res"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib9","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.ajog.2010.03.008","article-title":"The diagnosis of polycystic ovary syndrome in adolescents","volume":"203","author":"Carmina","year":"2010","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib10","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1210\/jcem-72-5-1008","article-title":"Comparison of sequential cyproterone acetate\/estrogen versus spironolactone\/oral contraceptive in the treatment of hirsutism","volume":"72","author":"O\u2019Brien","year":"1991","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib11","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/S0015-0282(97)00371-3","article-title":"Comparison of finasteride versus spironolactone in the treatment of idiopathic hirsutism","volume":"68","author":"Erenus","year":"1997","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib12","first-page":"89","article-title":"Comparison of spironolactone, flutamide, and finasteride efficacy in the treatment of hirsutism: a randomized, double blind, placebo-controlled trial","volume":"85","author":"Moghetti","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib13","doi-asserted-by":"crossref","first-page":"4116","DOI":"10.1210\/jc.2003-030424","article-title":"Metformin or antiandrogen in the treatment of hirsutism in polycystic ovary syndrome","volume":"88","author":"Harborne","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib14","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1210\/jc.2007-2429","article-title":"Clinical review: insulin sensitizers for the treatment of hirsutism: a systematic review and metaanalyses of randomized controlled trials","volume":"93","author":"Cosma","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib15","doi-asserted-by":"crossref","first-page":"197","DOI":"10.2165\/00128071-200102030-00009","article-title":"Topical eflornithine","volume":"2","author":"Balfour","year":"2001","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib16","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1097\/00006254-200211000-00022","article-title":"New approach to polycystic ovary syndrome and other forms of anovulatory infertility","volume":"57","author":"Laven","year":"2002","journal-title":"Obstet Gynecol Surv"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib17","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1093\/aje\/kwn137","article-title":"A simple screening approach for assessing community prevalence and phenotype of polycystic ovary syndrome in a semi-urban population in Sri Lanka","volume":"168","author":"Kumarapeli","year":"2008","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib18","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1111\/j.1447-0756.2007.00631.x","article-title":"Clinical, endocrine and ultrasonographic features of polycystic ovary syndrome in Thai women","volume":"33","author":"Vutyavanich","year":"2007","journal-title":"J Obstet Gynaecol Res"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib19","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0015-0282(16)54892-4","article-title":"Women with polycystic ovary syndrome wedge resected in 1956 to 1965: a long-term follow-up focusing on natural history and circulating hormones","volume":"57","author":"Dahlgren","year":"1992","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib20","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1046\/j.1365-2265.2001.01412.x","article-title":"Obesity, rather than menstrual cycle pattern or follicle cohort size, determines hyperinsulinaemia, dyslipidaemia and hypertension in ageing women with polycystic ovary syndrome","volume":"55","author":"Elting","year":"2001","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib21","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1055\/s-2007-992931","article-title":"Oral contraceptives in polycystic ovary syndrome: risk-benefit assessment","volume":"26","author":"Yildiz","year":"2008","journal-title":"Semin Reprod Med"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib22","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1093\/humrep\/dem005","article-title":"Metformin versus oral contraceptive pill in polycystic ovary syndrome: a Cochrane review","volume":"22","author":"Costello","year":"2007","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib23","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1097\/01.ogx.0000243772.33357.84","article-title":"Polycystic ovary syndrome and mental health: a review","volume":"61","author":"Himelein","year":"2006","journal-title":"Obstet Gynecol Surv"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib24","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/humupd\/dmm030","article-title":"Health-related quality of life measurement in women with polycystic ovary syndrome: a systematic review","volume":"14","author":"Jones","year":"2008","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib25","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1097\/AOG.0b013e318202b0a4","article-title":"Increased risk for abnormal depression scores in women with polycystic ovary syndrome: a systematic review and meta-analysis","volume":"117","author":"Dokras","year":"2011","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib26","first-page":"1976","article-title":"Development of a health-related quality-of-life questionnaire (PCOSQ) for women with polycystic ovary syndrome (PCOS)","volume":"83","author":"Cronin","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib27","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1097\/OGX.0b013e31815e85fc","article-title":"Polycystic ovary syndrome and oocyte developmental competence","volume":"63","author":"Dumesic","year":"2008","journal-title":"Obstet Gynecol Surv"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib28","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/j.fertnstert.2006.12.018","article-title":"Lack of association between polycystic ovary syndrome and embryonic aneuploidy","volume":"88","author":"Weghofer","year":"2007","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib29","first-page":"CD003053","article-title":"Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility","volume":"1","author":"Tang","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib30","doi-asserted-by":"crossref","first-page":"E448","DOI":"10.1210\/jc.2010-0853","article-title":"Metformin versus placebo from first trimester to delivery in polycystic ovary syndrome: a randomized, controlled multicenter study","volume":"95","author":"Vanky","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib31","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1093\/humupd\/dml036","article-title":"A meta-analysis of pregnancy outcomes in women with polycystic ovary syndrome","volume":"12","author":"Boomsma","year":"2006","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib32","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/j.fertnstert.2005.03.051","article-title":"Polycystic ovary syndrome in Mexican-Americans: prevalence and association with the severity of insulin resistance","volume":"84","author":"Goodarzi","year":"2005","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib33","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1093\/humrep\/deq310","article-title":"Phenotype and metabolic profile of South Asian women with polycystic ovary syndrome (PCOS): results of a large database from a specialist endocrine clinic","volume":"26","author":"Wijeyaratne","year":"2011","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib34","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1210\/jc.2005-2430","article-title":"Epidemiology and adverse cardiovascular risk profile of diagnosed polycystic ovary syndrome","volume":"91","author":"Lo","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib35","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1016\/j.fertnstert.2008.06.037","article-title":"Abdominal fat distribution and insulin resistance in Indian women with polycystic ovarian syndrome","volume":"91","author":"Kalra","year":"2009","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib36","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.ejogrb.2005.03.010","article-title":"Obesity and extreme obesity, manifest by ages 20\u201324 years, continuing through 32\u201341 years in women, should alert physicians to the diagnostic likelihood of polycystic ovary syndrome as a reversible underlying endocrinopathy","volume":"122","author":"Glueck","year":"2005","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib37","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1111\/j.1365-2265.2007.02742.x","article-title":"Quality of life and psychological morbidity in women with polycystic ovary syndrome: body mass index, age and the provision of patient information are significant modifiers","volume":"66","author":"Ching","year":"2007","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib38","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1111\/j.1471-0528.2006.00973.x","article-title":"The central issue? Visceral fat mass is a good marker of insulin resistance and metabolic disturbance in women with polycystic ovary syndrome","volume":"113","author":"Lord","year":"2006","journal-title":"BJOG"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib39","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1016\/j.fertnstert.2008.09.018","article-title":"Treatment of obesity in polycystic ovary syndrome: a position statement of the Androgen Excess and Polycystic Ovary Syndrome Society","volume":"92","author":"Moran","year":"2009","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib40","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1093\/humupd\/dmq001","article-title":"Impaired glucose tolerance, type 2 diabetes and metabolic syndrome in polycystic ovary syndrome: a systematic review and meta-analysis","volume":"16","author":"Moran","year":"2010","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib41","first-page":"774","article-title":"Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis","volume":"18","author":"Dunaif","year":"1997","journal-title":"Endocr Rev"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib42","doi-asserted-by":"crossref","first-page":"2571","DOI":"10.1210\/jc.2004-0219","article-title":"Polycystic ovaries are common in women with hyperandrogenic chronic anovulation but do not predict metabolic or reproductive phenotype","volume":"90","author":"Legro","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib43","doi-asserted-by":"crossref","first-page":"4965","DOI":"10.1210\/jc.2010-0202","article-title":"The polycystic ovary post-Rotterdam: a common, age-dependent finding in ovulatory women without metabolic significance","volume":"95","author":"Johnstone","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib44","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1172\/JCI118064","article-title":"Insulin secretory defects in polycystic ovary syndrome: relationship to insulin sensitivity and family history of non-insulin-dependent diabetes mellitus","volume":"96","author":"Ehrmann","year":"1995","journal-title":"J Clin Invest"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib45","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1001\/jama.286.19.2421","article-title":"Long or highly irregular menstrual cycles as a marker for risk of type 2 diabetes mellitus","volume":"286","author":"Solomon","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib46","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1111\/j.1365-2265.2007.02764.x","article-title":"Metabolic characteristics of women with polycystic ovaries and oligo-amenorrhoea but normal androgen levels: implications for the management of polycystic ovary syndrome","volume":"66","author":"Barber","year":"2007","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib47","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1111\/j.1365-2265.2010.03934.x","article-title":"When should an insulin sensitizing agent be used in the treatment of polycystic ovary syndrome?","volume":"74","author":"Franks","year":"2011","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib48","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1093\/humrep\/deq028","article-title":"Appropriate BMI levels for PCOS patients in Southern China","volume":"25","author":"Chen","year":"2010","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib49","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.ijgo.2009.09.021","article-title":"Association of biochemical hyperandrogenism with type 2 diabetes and obesity in Chinese women with polycystic ovary syndrome","volume":"108","author":"Zhao","year":"2010","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib50","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S0895-4356(98)00035-3","article-title":"Mortality of women with polycystic ovary syndrome at long-term follow-up","volume":"51","author":"Pierpoint","year":"1998","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib51","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1093\/humrep\/15.4.785","article-title":"Increased risk of non-insulin dependent diabetes mellitus, arterial hypertension and coronary artery disease in perimenopausal women with a history of the polycystic ovary syndrome","volume":"15","author":"Cibula","year":"2000","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib52","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1080\/1464727002000198781","article-title":"Long-term consequences of polycystic ovary syndrome: results of a 31 year follow-up study","volume":"3","author":"Wild","year":"2000","journal-title":"Hum Fertil (Camb)"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib53","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1210\/jc.2007-0425","volume":"93","author":"Shaw","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib54","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1097\/GME.0b013e31802cc7ab","article-title":"Searching for polycystic ovary syndrome in postmenopausal women: evidence of a dose-effect association with prevalent cardiovascular disease","volume":"14","author":"Krentz","year":"2007","journal-title":"Menopause"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib55","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/0029-7844(96)00226-8","article-title":"Epithelial ovarian cancer risk among women with polycystic ovary syndrome","volume":"88","author":"Schildkraut","year":"1996","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib56","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/S1472-6483(10)60175-7","article-title":"Polycystic ovary syndrome and the risk of gynaecological cancer: a systematic review","volume":"19","author":"Chittenden","year":"2009","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib57","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1093\/humrep\/deh373","article-title":"Changes in anti-m\u00fcllerian hormone serum concentrations over time suggest delayed ovarian ageing in normogonadotrophic anovulatory infertility","volume":"19","author":"Mulders","year":"2004","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib58","doi-asserted-by":"crossref","first-page":"3847","DOI":"10.1210\/jc.2005-0212","article-title":"Androgen levels in adult females: changes with age, menopause, and oophorectomy","volume":"90","author":"Davison","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib59","doi-asserted-by":"crossref","first-page":"4961","DOI":"10.1210\/jc.2009-0839","article-title":"Criteria for polycystic ovarian morphology in polycystic ovary syndrome as a function of age","volume":"94","author":"Alsamarai","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib60","doi-asserted-by":"crossref","unstructured":"Hudecova M, Holte J, Olovsson M, Sundstrom Poromea I. Long-term follow-up of patients with polycystic ovary syndrome: reproductive outcome and ovarian reserve. Hum Reprod 2009;24:1176\u201383.","DOI":"10.1093\/humrep\/den482"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib61","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1093\/humrep\/deq088","article-title":"Is polycystic ovary syndrome an exception for reproductive aging?","volume":"25","author":"Tehrani","year":"2010","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib62","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.ajog.2010.03.008","article-title":"The diagnosis of polycystic ovary syndrome in adolescents","volume":"203","author":"Carmina","year":"2010","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib63","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1111\/j.1471-0528.2009.02421.x","article-title":"Reproductive endocrinology of adolescent polycystic ovary syndrome","volume":"117","author":"Shayya","year":"2010","journal-title":"BJOG"},{"issue":"Suppl 1","key":"10.1016\/j.fertnstert.2011.09.024_bib64","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.1016\/j.fertnstert.2006.04.015","article-title":"Clinical expression of polycystic ovary syndrome in adolescent girls","volume":"86","author":"Sultan","year":"2006","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib65","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.jpag.2007.07.004","article-title":"Adolescent female acne: etiology and management","volume":"21","author":"Olutunmbi","year":"2008","journal-title":"J Pediatr Adolesc Gynecol"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib66","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1097\/GRF.0b013e31802f50fc","article-title":"Polycystic ovary syndrome: early detection in the adolescent","volume":"50","author":"Jeffrey","year":"2007","journal-title":"Clin Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib67","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1196\/annals.1429.005","article-title":"Polycystic ovary syndrome in adolescence","volume":"1135","author":"Blank","year":"2008","journal-title":"Ann NY Acad Sci"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib68","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1677\/joe.0.0970213","article-title":"Incidence of ovulation in the years after the menarche","volume":"97","author":"Metcalf","year":"1983","journal-title":"J Endocrinol"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib69","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1159\/000180567","article-title":"Menstrual irregularities in adolescents: hormonal pattern and ovarian morphology","volume":"24","author":"Venturoli","year":"1986","journal-title":"Horm Res"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib70","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1080\/00016340802478166","article-title":"Prospective follow-up of menstrual disorders in adolescence and prognostic factors","volume":"87","author":"Wiksten-Almstromer","year":"2008","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib71","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1093\/humrep\/deh079","article-title":"Predictive value of menstrual cycle pattern, body mass index, hormone levels and polycystic ovaries at age 15 years for oligo-amenorrhoea at age 18 years","volume":"19","author":"van Hooff","year":"2004","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib72","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1203\/00006450-199512000-00024","article-title":"Longitudinal change of sonographic ovarian aspects and endocrine parameters in irregular cycles of adolescence","volume":"38","author":"Venturoli","year":"1995","journal-title":"Pediatr Res"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib73","doi-asserted-by":"crossref","first-page":"3786","DOI":"10.1210\/jc.2006-0835","article-title":"Functional significance of polycystic-size ovaries in healthy adolescents","volume":"91","author":"Mortensen","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib74","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/(SICI)1097-0096(199606)24:5<243::AID-JCU3>3.0.CO;2-E","article-title":"Relevance of the determination of ovarian volume in adolescent girls with menstrual disorders","volume":"24","author":"Herter","year":"1996","journal-title":"J Clin Ultrasound"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib75","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1210\/jc.2008-1252","article-title":"Maturation of luteinizing hormone (gonadotropin-releasing hormone) secretion across puberty: evidence for altered regulation in obese peripubertal girls","volume":"94","author":"McCartney","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib76","doi-asserted-by":"crossref","unstructured":"Blok GJ, de Boer H, Gooren LJ, van der Veen EA. Growth hormone substitution in adult growth hormone-deficient men augments androgen effects on the skin. Clin Endocrinol (Oxf) 1997;47:29\u201336.","DOI":"10.1046\/j.1365-2265.1997.2021027.x"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib77","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1046\/j.1365-2133.2000.03521.x","article-title":"Thyroid hormone and hair growth","volume":"142","author":"Messenger","year":"2000","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib78","first-page":"1","article-title":"Vaniqa\u2014eflornithine 13.9% cream","volume":"6","author":"Shapiro","year":"2001","journal-title":"Skin Ther Lett"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib79","series-title":"Clinical gynecologic endocrinology and infertility","first-page":"523","article-title":"Hirsutism","author":"Speroff","year":"1999"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib80","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1159\/000067823","article-title":"Update and future of hormonal therapy in acne","volume":"206","author":"Thiboutot","year":"2003","journal-title":"Dermatology"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib81","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/S0015-0282(00)01526-0","article-title":"The time has come to simplify the evaluation of the hirsute patient","volume":"74","author":"Azziz","year":"2000","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib82","doi-asserted-by":"crossref","first-page":"4116","DOI":"10.1210\/jc.2003-030424","article-title":"Metformin or antiandrogen in the treatment of hirsutism in polycystic ovary syndrome","volume":"88","author":"Harborne","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib83","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.clindermatol.2006.04.004","article-title":"Dermatology of androgen-related disorders","volume":"24","author":"Essah","year":"2006","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib84","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/j.1529-8019.2006.00077.x","article-title":"Diagnosis and management of the dermatologic manifestations of the polycystic ovary syndrome","volume":"19","author":"Lowenstein","year":"2006","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib85","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/S0190-9622(88)70241-8","article-title":"The prevalence of hyperandrogenism in 109 consecutive female patients with diffuse alopecia","volume":"19","author":"Futterweit","year":"1988","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib86","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1530\/eje.0.1490439","article-title":"Prevalence of polycystic ovaries in women with androgenic alopecia","volume":"149","author":"Cela","year":"2003","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib87","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/S0733-8635(05)70396-X","article-title":"Androgen metabolism as it affects hair growth in androgenetic alopecia","volume":"14","author":"Kaufman","year":"1996","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib88","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1111\/1523-1747.ep12335779","article-title":"Different levels of 5\u03b1-reductase type I and II, aromatase, and androgen receptor in hair follicles of women and men with androgenetic alopecia","volume":"109","author":"Sawaya","year":"1997","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib89","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/humrep\/deh098","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)","volume":"19","year":"2004","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib90","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.fertnstert.2003.10.004","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome","volume":"81","year":"2004","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib91","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.bpobgyn.2004.05.001","article-title":"Definitions, prevalence and symptoms of polycystic ovaries and polycystic ovary syndrome","volume":"18","author":"Hart","year":"2004","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib92","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1097\/00006254-200211000-00022","article-title":"New approach to polycystic ovary syndrome and other forms of anovulatory infertility","volume":"57","author":"Laven","year":"2002","journal-title":"Obstet Gynecol Surv"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib93","first-page":"1626","article-title":"Troglitazone improves ovulation and hirsutism in the polycystic ovary syndrome: a multicenter, double blind, placebo-controlled trial","volume":"86","author":"Azziz","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib94","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1093\/aje\/kwn137","article-title":"A simple screening approach for assessing community prevalence and phenotype of polycystic ovary syndrome in a semi-urban population in Sri Lanka","volume":"168","author":"Kumarapeli","year":"2008","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib95","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/S1043-2760(98)00020-4","article-title":"Endocrine and metabolic abnormalities in adolescents with a PCOS-like condition: consequences for adult reproduction","volume":"9","author":"Apter","year":"1998","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib96","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jpag.2009.04.004","article-title":"Characteristics of adolescents presenting to a multidisciplinary clinic for polycystic ovarian syndrome","volume":"23","author":"Bekx","year":"2010","journal-title":"J Pediatr Adolesc Gynecol"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib97","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0015-0282(16)54892-4","article-title":"Women with polycystic ovary syndrome wedge resected in 1956 to 1965: a long-term follow-up focusing on natural history and circulating hormones","volume":"57","author":"Dahlgren","year":"1992","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib98","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1093\/humrep\/15.1.24","article-title":"Women with polycystic ovary syndrome gain regular menstrual cycles when ageing","volume":"15","author":"Elting","year":"2000","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib99","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1016\/S0015-0282(03)00152-3","article-title":"Aging women with polycystic ovary syndrome who achieve regular menstrual cycles have a smaller follicle cohort than those who continue to have irregular cycles","volume":"79","author":"Elting","year":"2003","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib100","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1210\/jc.2003-030932","article-title":"Anti-m\u00fcllerian hormone serum concentrations in normoovulatory and anovulatory women of reproductive age","volume":"89","author":"Laven","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib101","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S0015-0282(01)02993-4","article-title":"Antimullerian hormone serum levels: a putative marker for ovarian aging","volume":"77","author":"de Vet","year":"2002","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib102","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1530\/rep.1.00529","article-title":"Anti-m\u00fcllerian hormone: a new marker for ovarian function","volume":"131","author":"Visser","year":"2006","journal-title":"Reproduction"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib103","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1093\/humrep\/deq088","article-title":"Is polycystic ovary syndrome an exception for reproductive aging?","volume":"25","author":"Tehrani","year":"2010","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib104","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1111\/j.1447-0756.2007.00631.x","article-title":"Clinical, endocrine and ultrasonographic features of polycystic ovary syndrome in Thai women","volume":"33","author":"Vutyavanich","year":"2007","journal-title":"J Obstet Gynaecol Res"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib105","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1093\/oxfordjournals.humrep.a136243","article-title":"Polycystic ovary syndrome: the spectrum of the disorder in 1741 patients","volume":"10","author":"Balen","year":"1995","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib106","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1111\/j.1365-2265.2007.02954.x","article-title":"Unravelling the phenotypic map of polycystic ovary syndrome (PCOS): a prospective study of 634 women with PCOS","volume":"67","author":"Diamanti-Kandarakis","year":"2007","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib107","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1210\/jc.2002-020982","article-title":"Hormonal profile of women with self-reported symptoms of oligomenorrhea and\/or hirsutism: Northern Finland birth cohort 1966 study","volume":"88","author":"Taponen","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib108","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.ejogrb.2009.12.024","article-title":"The degree of cycle irregularity correlates with the grade of endocrine and metabolic disorders in PCOS patients","volume":"149","author":"Strowitzki","year":"2010","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib109","doi-asserted-by":"crossref","first-page":"4961","DOI":"10.1210\/jc.2009-0839","article-title":"Criteria for polycystic ovarian morphology in polycystic ovary syndrome as a function of age","volume":"94","author":"Alsamarai","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib110","doi-asserted-by":"crossref","first-page":"E485","DOI":"10.1210\/jc.2009-2717","article-title":"Oligoovulatory and anovulatory cycles in women with polycystic ovary syndrome (PCOS): what\u2019s the difference?","volume":"95","author":"Burgers","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib111","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1016\/j.fertnstert.2008.02.161","article-title":"Influence of sociocultural factors on the ovulatory status of polycystic ovary syndrome","volume":"91","author":"Di","year":"2009","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib112","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1093\/humrep\/den136","article-title":"Fecundability and spontaneous abortions in women with self-reported oligo-amenorrhea and\/or hirsutism: Northern Finland Birth Cohort 1966 Study","volume":"23","author":"Koivunen","year":"2008","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib113","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0015-0282(01)02929-6","article-title":"A nomogram to predict the probability of live birth after clomiphene citrate induction of ovulation in normogonadotropic oligoamenorrheic infertility","volume":"77","author":"Imani","year":"2002","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib114","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1093\/humrep\/deq142","article-title":"Prestimulation parameters predicting live birth in anovulatory WHO Group II patients undergoing ovulation induction with gonadotrophins","volume":"25","author":"Nyboe","year":"2010","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib115","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/humupd\/dmm030","article-title":"Health-related quality of life measurement in women with polycystic ovary syndrome: a systematic review","volume":"14","author":"Jones","year":"2008","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib116","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1530\/eje.1.02024","article-title":"Clinical and psychological correlates of quality-of-life in polycystic ovary syndrome","volume":"153","author":"Hahn","year":"2005","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib117","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1093\/humrep\/deq068","article-title":"Psychological well-being and sexarche in women with polycystic ovary syndrome","volume":"25","author":"de Niet","year":"2010","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib118","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1210\/jcem.87.5.8471","article-title":"Menstrual cycle irregularity and risk for future cardiovascular disease","volume":"87","author":"Solomon","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib119","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1210\/jc.2003-031720","article-title":"Metabolic cardiovascular disease risk factors in women with self-reported symptoms of oligomenorrhea and\/or hirsutism: Northern Finland Birth Cohort 1966 Study","volume":"89","author":"Taponen","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib120","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1046\/j.1365-2265.2001.01412.x","article-title":"Obesity, rather than menstrual cycle pattern or follicle cohort size, determines hyperinsulinaemia, dyslipidaemia and hypertension in ageing women with polycystic ovary syndrome","volume":"55","author":"Elting","year":"2001","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib121","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.maturitas.2008.12.018","article-title":"Progestogen deficiency and endometrial cancer risk","volume":"62","author":"Schindler","year":"2009","journal-title":"Maturitas"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib122","first-page":"325","article-title":"Ultrasound and menstrual history in predicting endometrial hyperplasia in polycystic ovary syndrome","volume":"98","author":"Cheung","year":"2001","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib123","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1093\/humupd\/dmi005","article-title":"Combined oral contraceptives in the treatment of polycystic ovary syndrome","volume":"11","author":"Vrbikova","year":"2005","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib124","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0002-9378(99)70182-1","article-title":"Estimates of the risk of cardiovascular death attributable to low-dose oral contraceptives in the United States","volume":"180","author":"Schwingl","year":"1999","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib125","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1016\/j.fertnstert.2006.01.009","article-title":"Past oral contraceptive use and angiographic coronary artery disease in postmenopausal women: data from the National Heart, Lung, and Blood Institute-sponsored Women\u2019s Ischemia Syndrome Evaluation","volume":"85","author":"Merz","year":"2006","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib126","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1055\/s-2007-992931","article-title":"Oral contraceptives in polycystic ovary syndrome: risk-benefit assessment","volume":"26","author":"Yildiz","year":"2008","journal-title":"Semin Reprod Med"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib127","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1093\/humrep\/dem005","article-title":"Metformin versus oral contraceptive pill in polycystic ovary syndrome: a Cochrane review","volume":"22","author":"Costello","year":"2007","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib128","first-page":"3074","article-title":"The effect of a desogestrel-containing oral contraceptive on glucose tolerance and leptin concentrations in hyperandrogenic women","volume":"82","author":"Nader","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib129","first-page":"3161","article-title":"Endocrine and metabolic effects of metformin versus ethinyl estradiol\u2013cyproterone acetate in obese women with polycystic ovary syndrome: a randomized study","volume":"85","author":"Morin-Papunen","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib130","doi-asserted-by":"crossref","first-page":"56","DOI":"10.3109\/00016349509009945","article-title":"Effects of long-term administration of an oral contraceptive containing ethinylestradiol and cyproterone acetate on lipid metabolism in women with polycystic ovary syndrome","volume":"74","author":"Falsetti","year":"1995","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib131","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1046\/j.1365-2265.1999.00701.x","article-title":"The natural history of the metabolic syndrome in young women with the polycystic ovary syndrome and the effect of long-term oestrogen-progestagen treatment","volume":"50","author":"Pasquali","year":"1999","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib132","first-page":"1","article-title":"New recommendations on the safety of contraceptive methods for women with medical conditions","volume":"44","author":"Gaffield","year":"2011","journal-title":"IPPF Med Bull"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib133","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1530\/eje.0.1500215","article-title":"Metabolic and endocrine effects of treatment with peroral or transdermal oestrogens in conjunction with peroral cyproterone acetate in women with polycystic ovary syndrome","volume":"150","author":"Vrbikova","year":"2004","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib134","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1016\/j.fertnstert.2009.05.044","article-title":"Polycystic ovary syndrome and cardiovascular risk in young patients treated with drospirenone-ethinylestradiol or contraceptive vaginal ring. A prospective, randomized, pilot study","volume":"94","author":"Battaglia","year":"2010","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib135","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1097\/01.ogx.0000243772.33357.84","article-title":"Polycystic ovary syndrome and mental health: a review","volume":"61","author":"Himelein","year":"2006","journal-title":"Obstet Gynecol Surv"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib136","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/S1472-6483(10)61182-0","article-title":"Effects of lifestyle modification in polycystic ovarian syndrome","volume":"12","author":"Moran","year":"2006","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib137","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.fertnstert.2007.09.041","article-title":"Consensus on infertility treatment related to polycystic ovary syndrome","volume":"89","year":"2008","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib138","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1093\/humrep\/dem426","article-title":"Consensus on infertility treatment related to polycystic ovary syndrome","volume":"23","year":"2008","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib139","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1097\/MED.0b013e3282f1cfc6","article-title":"Dietary effects on fertility treatment and pregnancy outcomes","volume":"14","author":"Lim","year":"2007","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib140","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1111\/j.1552-6909.2006.00047.x","article-title":"The lived experience of women diagnosed with polycystic ovary syndrome","volume":"35","author":"Snyder","year":"2006","journal-title":"J Obstet Gynecol Neonatal Nurs"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib141","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S0277-9536(01)00034-X","article-title":"\u201cThe thief of womanhood\u201d: women\u2019s experience of polycystic ovarian syndrome","volume":"54","author":"Kitzinger","year":"2002","journal-title":"Soc Sci Med"},{"issue":"Suppl 1","key":"10.1016\/j.fertnstert.2011.09.024_bib142","first-page":"S93","article-title":"Quality of life and marital sexual satisfaction in women with polycystic ovary syndrome","volume":"45","author":"Drosdzol","year":"2007","journal-title":"Folia Histochem Cytobiol"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib143","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.bbi.2007.07.003","article-title":"Obesity, depression, and chronic low-grade inflammation in women with polycystic ovary syndrome","volume":"22","author":"Benson","year":"2008","journal-title":"Brain Behav Immun"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib144","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1093\/humrep\/den227","article-title":"Psychological implications of infertility in women with polycystic ovary syndrome","volume":"23","author":"Tan","year":"2008","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib145","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1093\/humrep\/dem108","article-title":"Quality of life and psychological well being in polycystic ovary syndrome","volume":"22","author":"Barnard","year":"2007","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib146","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.psyneuen.2008.12.001","article-title":"Disturbed stress responses in women with polycystic ovary syndrome","volume":"34","author":"Benson","year":"2009","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib147","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1016\/j.fertnstert.2009.09.018","article-title":"Anxiety and depression in polycystic ovary syndrome: a comprehensive investigation","volume":"93","author":"Deeks","year":"2010","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib148","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.fertnstert.2007.11.022","article-title":"Risk of depression and other mental health disorders in women with polycystic ovary syndrome: a longitudinal study","volume":"91","author":"Kerchner","year":"2009","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib149","doi-asserted-by":"crossref","first-page":"24","DOI":"10.3109\/01674820903477593","article-title":"Polycystic ovary syndrome: a biopsychosocial understanding in young women to improve knowledge and treatment options","volume":"31","author":"Moran","year":"2010","journal-title":"J Psychosom Obstet Gynaecol"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib150","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1093\/humupd\/dmq001","article-title":"Impaired glucose tolerance, type 2 diabetes and metabolic syndrome in polycystic ovary syndrome: a systematic review and meta-analysis","volume":"16","author":"Moran","year":"2010","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib151","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1016\/j.fertnstert.2010.02.057","article-title":"The effect of modifying dietary protein and carbohydrate in weight loss on arterial compliance and postprandial lipidemia in overweight women with polycystic ovary syndrome","volume":"94","author":"Moran","year":"2010","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib152","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1016\/j.psyneuen.2008.06.003","article-title":"Women with polycystic ovary syndrome are often depressed or anxious\u2014a case control study","volume":"33","author":"Mansson","year":"2008","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib153","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1093\/humrep\/dep384","article-title":"Anxiety and depression symptoms in women with polycystic ovary syndrome compared with controls matched for body mass index","volume":"25","author":"Jedel","year":"2010","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib154","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1111\/j.1365-2265.2007.02742.x","article-title":"Quality of life and psychological morbidity in women with polycystic ovary syndrome: body mass index, age and the provision of patient information are significant modifiers","volume":"66","author":"Ching","year":"2007","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib155","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/j.fertnstert.2009.08.006","article-title":"Improvement in quality-of-life questionnaire measures in obese adolescent females with polycystic ovary syndrome treated with lifestyle changes and oral contraceptives, with or without metformin","volume":"93","author":"Harris-Glocker","year":"2010","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib156","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1080\/01674820802546204","article-title":"Anxiety and depression in adolescents with polycystic ovary syndrome and Mayer-Rokitansky-Kuster-Hauser syndrome","volume":"30","author":"Laggari","year":"2009","journal-title":"J Psychosom Obstet Gynaecol"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib157","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1093\/jpepsy\/jsn057","article-title":"Cognitive-behavioral therapy for physical and emotional disturbances in adolescents with polycystic ovary syndrome: a pilot study","volume":"34","author":"Rofey","year":"2009","journal-title":"J Pediatr Psychol"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib158","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1177\/147323000803600604","article-title":"The relationship between clinico-biochemical characteristics and psychiatric distress in young women with polycystic ovary syndrome","volume":"36","author":"Adali","year":"2008","journal-title":"J Int Med Res"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib159","first-page":"945","article-title":"Psychosocial aspects of women with polycystic ovary syndrome from south India","volume":"56","author":"Sundararaman","year":"2008","journal-title":"J Assoc Physicians India"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib160","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1016\/j.fertnstert.2006.11.039","article-title":"Increased risk of depressive disorders in women with polycystic ovary syndrome","volume":"87","author":"Hollinrake","year":"2007","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib161","doi-asserted-by":"crossref","first-page":"2886","DOI":"10.1111\/j.1743-6109.2008.01010.x","article-title":"PCOS, sexuality, and clitoral vascularisation: a pilot study","volume":"5","author":"Battaglia","year":"2008","journal-title":"J Sex Med"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib162","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/SPV.0b013e318062225e","article-title":"Sexual dysfunction in women with polycystic ovary syndrome: the effects of testosterone, obesity, and depression","volume":"13","author":"Anger","year":"2007","journal-title":"Female Pelvic Med Reconstr Surg"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib163","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S1083-3188(02)00205-X","article-title":"Fertility concerns and sexual behavior in adolescent girls with polycystic ovary syndrome: implications for quality of life","volume":"16","author":"Trent","year":"2003","journal-title":"J Pediatr Adolesc Gynecol"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib164","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1016\/j.fertnstert.2009.11.001","article-title":"Lifestyle management improves quality of life and depression in overweight and obese women with polycystic ovary syndrome","volume":"94","author":"Thomson","year":"2010","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib165","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1093\/humrep\/dem391","article-title":"Structured exercise training programme versus hypocaloric hyperproteic diet in obese polycystic ovary syndrome patients with anovulatory infertility: a 24-week pilot study","volume":"23","author":"Palomba","year":"2008","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib166","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.jpsychores.2006.01.016","article-title":"Women living with facial hair: the psychological and behavioral burden","volume":"61","author":"Lipton","year":"2006","journal-title":"J Psychosom Res"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib167","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1111\/j.1365-2648.2009.05061.x","article-title":"Nurse-led peer support group: experiences of women with polycystic ovary syndrome","volume":"65","author":"Percy","year":"2009","journal-title":"J Adv Nurs"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib168","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1093\/humrep\/dep031","article-title":"Prevalence and implications of anxiety in polycystic ovary syndrome: results of an internet-based survey in Germany","volume":"24","author":"Benson","year":"2009","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib169","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1586\/17474108.3.6.775","article-title":"Polycystic ovary syndrome as a developmental disorder","volume":"3","author":"Goverde","year":"2008","journal-title":"Exp Rev Obstret Gynecol"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib170","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1111\/j.1524-4733.2010.00696.x","article-title":"The suitability of polycystic ovary syndrome-specific questionnaires for measuring the impact of PCOS on quality of life in clinical trials","volume":"13","author":"Malik-Aslam","year":"2010","journal-title":"Value Health"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib171","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1093\/annonc\/mdi031","article-title":"Workgroup I: criteria for screening. UICC International Workshop on Facilitating Screening for Colorectal Cancer, Oslo, Norway (29 and 30 June 2002)","volume":"16","author":"Boyle","year":"2005","journal-title":"Ann Oncol"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib172","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1016\/S0277-9536(03)00138-2","article-title":"A review of psychosocial interventions in infertility","volume":"57","author":"Boivin","year":"2003","journal-title":"Soc Sci Med"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib173","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1097\/OGX.0b013e31815e85fc","article-title":"Polycystic ovary syndrome and oocyte developmental competence","volume":"63","author":"Dumesic","year":"2008","journal-title":"Obstet Gynecol Surv"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib174","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/j.fertnstert.2006.12.018","article-title":"Lack of association between polycystic ovary syndrome and embryonic aneuploidy","volume":"88","author":"Weghofer","year":"2007","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib175","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/humrep\/deh609","article-title":"Impaired insulin-dependent glucose metabolism in granulosa-lutein cells from anovulatory women with polycystic ovaries","volume":"20","author":"Rice","year":"2005","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib176","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.2337\/db07-0275","article-title":"Reduced expression of nuclear-encoded genes involved in mitochondrial oxidative metabolism in skeletal muscle of insulin-resistant women with polycystic ovary syndrome","volume":"56","author":"Skov","year":"2007","journal-title":"Diabetes"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib177","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1210\/jc.2006-2123","article-title":"Molecular abnormalities in oocytes from women with polycystic ovary syndrome revealed by microarray analysis","volume":"92","author":"Wood","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib178","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1093\/humrep\/deq181","article-title":"Metabolism and karyotype analysis of oocytes from patients with polycystic ovary syndrome","volume":"25","author":"Harris","year":"2010","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib179","doi-asserted-by":"crossref","first-page":"2789","DOI":"10.1210\/jc.2006-0069","article-title":"Epigenetic modification of the X chromosome influences susceptibility to polycystic ovary syndrome","volume":"91","author":"Hickey","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib180","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.mehy.2006.09.076","article-title":"Epigenetic abnormality: a possible mechanism underlying the fetal origin of polycystic ovary syndrome","volume":"70","author":"Li","year":"2008","journal-title":"Med Hypotheses"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib181","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.beem.2006.03.009","article-title":"Pregnancy complications in PCOS","volume":"20","author":"Homburg","year":"2006","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib182","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1056\/NEJMoa063971","article-title":"Clomiphene, metformin, or both for infertility in the polycystic ovary syndrome","volume":"356","author":"Legro","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib183","first-page":"CD003053","article-title":"Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility","volume":"1","author":"Tang","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib184","doi-asserted-by":"crossref","first-page":"E448","DOI":"10.1210\/jc.2010-0853","article-title":"Metformin versus placebo from first trimester to delivery in polycystic ovary syndrome: a randomized, controlled multicenter study","volume":"95","author":"Vanky","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib185","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.beem.2006.03.005","article-title":"Endometrium in PCOS: implantation and predisposition to endocrine CA","volume":"20","author":"Giudice","year":"2006","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib186","doi-asserted-by":"crossref","first-page":"3123","DOI":"10.1093\/humrep\/deq272","article-title":"Sex hormone-binding globulin concentrations before conception as a predictor for gestational diabetes in women with polycystic ovary syndrome","volume":"25","author":"Veltman-Verhulst","year":"2010","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib187","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1093\/humupd\/dml036","article-title":"A meta-analysis of pregnancy outcomes in women with polycystic ovary syndrome","volume":"12","author":"Boomsma","year":"2006","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib188","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1111\/j.1471-0528.2010.02525.x","article-title":"Uterine blood flow in pregnant patients with polycystic ovary syndrome: relationships with clinical outcomes","volume":"117","author":"Palomba","year":"2010","journal-title":"BJOG"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib189","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1097\/GCO.0b013e328328d3c7","article-title":"Risks and management of obesity in pregnancy: current controversies","volume":"21","author":"Wax","year":"2009","journal-title":"Curr Opin Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib190","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1093\/humupd\/dmp050","article-title":"Maternal metabolism and obesity: modifiable determinants of pregnancy outcome","volume":"16","author":"Nelson","year":"2010","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib191","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1016\/j.fertnstert.2008.08.087","article-title":"Effect of preconceptional metformin on abortion risk in polycystic ovary syndrome: a systematic review and meta-analysis of randomized controlled trials","volume":"92","author":"Palomba","year":"2009","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib192","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1093\/humrep\/deh347","article-title":"Metformin reduces pregnancy complications without affecting androgen levels in pregnant polycystic ovary syndrome women: results of a randomized study","volume":"19","author":"Vanky","year":"2004","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib193","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.2337\/diab.42.10.1462","article-title":"Ethnicity and polycystic ovary syndrome are associated with independent and additive decreases in insulin action in Caribbean-Hispanic women","volume":"42","author":"Dunaif","year":"1993","journal-title":"Diabetes"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib194","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1067\/mob.2002.126650","article-title":"Polycystic ovarian syndrome and insulin resistance in white and Mexican American women: a comparison of two distinct populations","volume":"187","author":"Kauffman","year":"2002","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib195","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1016\/j.fertnstert.2005.09.046","article-title":"Hyperinsulinemia and circulating dehydroepiandrosterone sulfate in white and Mexican American women with polycystic ovary syndrome","volume":"85","author":"Kauffman","year":"2006","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib196","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/j.fertnstert.2005.03.051","article-title":"Polycystic ovary syndrome in Mexican-Americans: prevalence and association with the severity of insulin resistance","volume":"84","author":"Goodarzi","year":"2005","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib197","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1016\/0002-9378(92)91779-A","article-title":"Does ethnicity influence the prevalence of adrenal hyperandrogenism and insulin resistance in polycystic ovary syndrome?","volume":"167","author":"Carmina","year":"1992","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib198","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.ejogrb.2007.12.018","article-title":"Prevalence of polycystic ovary syndrome in unselected women from southern China","volume":"139","author":"Chen","year":"2008","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib199","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1055\/s-2007-992920","article-title":"Polycystic ovary syndrome in Asian women","volume":"26","author":"Ng","year":"2008","journal-title":"Semin Reprod Med"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib200","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/1471-2350-7-36","article-title":"Abnormal glucose tolerance and insulin resistance in polycystic ovary syndrome amongst the Taiwanese population\u2014not correlated with insulin receptor substrate-1 Gly972Arg\/Ala513Pro polymorphism","volume":"7","author":"Lin","year":"2006","journal-title":"BMC Med Genet"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib201","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.ijgo.2007.01.005","article-title":"Clinical and metabolic features of polycystic ovary syndrome","volume":"97","author":"Li","year":"2007","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib202","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/S0015-0282(16)57297-5","article-title":"Ethnic differences in insulin and glucose response to glucose between white and Indian women with polycystic ovary syndrome","volume":"63","author":"Norman","year":"1995","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib203","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1046\/j.1365-2265.1998.00492.x","article-title":"Polycystic ovaries and associated metabolic abnormalities in Indian subcontinent Asian women","volume":"49","author":"Rodin","year":"1998","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib204","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1046\/j.1365-2265.2002.01603.x","article-title":"Clinical manifestations and insulin resistance (IR) in polycystic ovary syndrome (PCOS) among South Asians and Caucasians: is there a difference?","volume":"57","author":"Wijeyaratne","year":"2002","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib205","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1111\/j.1365-2265.2004.02019.x","article-title":"Plasma homocysteine in polycystic ovary syndrome: does it correlate with insulin resistance and ethnicity?","volume":"60","author":"Wijeyaratne","year":"2004","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib206","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1089\/1540419031361435","article-title":"Risk of atherosclerosis in women with polycystic ovary syndrome: a study from South India","volume":"1","author":"Sundararaman","year":"2003","journal-title":"Metab Syndr Relat Disord"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib207","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1016\/j.fertnstert.2008.06.037","article-title":"Abdominal fat distribution and insulin resistance in Indian women with polycystic ovarian syndrome","volume":"91","author":"Kalra","year":"2009","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib208","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1080\/09513590500216776","article-title":"Acanthosis nigricans: clinical predictor of abnormal glucose tolerance in Asian women with polycystic ovary syndrome","volume":"21","author":"Charnvises","year":"2005","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib209","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1080\/09513590701214158","article-title":"Prevalence of the metabolic syndrome in Asian women with polycystic ovary syndrome: using the International Diabetes Federation criteria","volume":"23","author":"Weerakiet","year":"2007","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib210","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1210\/jc.2005-2430","article-title":"Epidemiology and adverse cardiovascular risk profile of diagnosed polycystic ovary syndrome","volume":"91","author":"Lo","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib211","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1210\/jc.2005-1329","article-title":"Prevalence and predictors of the metabolic syndrome in women with polycystic ovary syndrome","volume":"91","author":"Ehrmann","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib212","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/j.fertnstert.2006.03.037","article-title":"The Pregnancy in Polycystic Ovary Syndrome study: baseline characteristics of the randomized cohort including racial effects","volume":"86","author":"Legro","year":"2006","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib213","doi-asserted-by":"crossref","first-page":"4361","DOI":"10.1210\/jc.2006-1191","article-title":"Defining constant versus variable phenotypic features of women with polycystic ovary syndrome using different ethnic groups and populations","volume":"91","author":"Welt","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib214","doi-asserted-by":"crossref","first-page":"4842","DOI":"10.1210\/jc.2006-1327","article-title":"Characterizing discrete subsets of polycystic ovary syndrome as defined by the Rotterdam criteria: the impact of weight on phenotype and metabolic features","volume":"91","author":"Welt","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib215","doi-asserted-by":"crossref","first-page":"4006","DOI":"10.1210\/jcem.84.11.6148","article-title":"A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile","volume":"84","author":"Diamanti-Kandarakis","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib216","first-page":"2434","article-title":"A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain","volume":"85","author":"Asuncion","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib217","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1093\/humrep\/dei100","article-title":"Evaluation of metabolic syndrome frequency and premature carotid atherosclerosis in young women with polycystic ovary syndrome","volume":"20","author":"Vural","year":"2005","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib218","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1111\/j.1479-828X.2001.tb01210.x","article-title":"The impact of ethnicity on the presentation of polycystic ovarian syndrome","volume":"41","author":"Williamson","year":"2001","journal-title":"Aust NZ J Obstet Gynaecol"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib219","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S1701-2163(16)30169-4","article-title":"Insulin responses to the oral glucose tolerance test in women of different ethnicity with polycystic ovary syndrome","volume":"27","author":"Al-Fozan","year":"2005","journal-title":"J Obstet Gynaecol Can"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib220","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1127\/anthranz\/62\/2004\/301","article-title":"Psychosocial and sociocultural aspects of infertility\u2014a comparison between Austrian women and immigrant women","volume":"62","author":"Schmid","year":"2004","journal-title":"Anthropol Anz"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib221","first-page":"71","article-title":"Clinical and biochemical characteristics of polycystic ovary syndrome in Benghazi-Libya: a retrospective study","volume":"3","author":"Najem","year":"2008","journal-title":"Libyan J Med"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib222","first-page":"28","article-title":"Hirsutism in Saudi females of reproductive age: a hospital-based study","volume":"28","author":"Al-Ruhaily","year":"2008","journal-title":"Ann Saudi Med"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib223","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1093\/humrep\/deq310","article-title":"Phenotype and metabolic profile of South Asian women with polycystic ovary syndrome (PCOS): results of a large database from a specialist endocrine clinic","volume":"26","author":"Wijeyaratne","year":"2011","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib224","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1507\/endocrj.K06-159","article-title":"Diagnostic performance of serum total testosterone for Japanese patients with polycystic ovary syndrome","volume":"54","author":"Iwasa","year":"2007","journal-title":"Endocr J"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib225","doi-asserted-by":"crossref","first-page":"3328","DOI":"10.1093\/humrep\/dei221","article-title":"Metabolic syndrome in young Czech women with polycystic ovary syndrome","volume":"20","author":"Vrbikova","year":"2005","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib226","series-title":"Current management of polycystic ovary syndrome","first-page":"25","article-title":"Ethnic variations in the expression of polycystic ovary syndrome","author":"Wijeyeratne","year":"2010"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib227","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1111\/j.1471-0528.2010.02799.x","article-title":"Health-related quality of life and psychological distress in polycystic ovary syndrome: a hidden facet in South Asian women","volume":"118","author":"Kumarapeli","year":"2011","journal-title":"BJOG"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib228","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.jadohealth.2009.10.008","article-title":"Obesity-related lipid profile and altered insulin incretion in adolescents with polycystic ovary syndrome","volume":"46","author":"Fulghesu","year":"2010","journal-title":"J Adolesc Health"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib229","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s00404-003-0537-2","article-title":"The effect of obesity on the outcome of infertility management in women with polycystic ovary syndrome","volume":"270","author":"Al-Azemi","year":"2004","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib230","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.ejogrb.2005.03.010","article-title":"Obesity and extreme obesity, manifest by ages 20\u201324 years, continuing through 32\u201341 years in women, should alert physicians to the diagnostic likelihood of polycystic ovary syndrome as a reversible underlying endocrinopathy","volume":"122","author":"Glueck","year":"2005","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib231","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1367\/A04-130R.1","article-title":"Overweight status of adolescent girls with polycystic ovary syndrome: body mass index as mediator of quality of life","volume":"5","author":"Trent","year":"2005","journal-title":"Ambul Pediatr"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib232","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1210\/jc.2005-1666","article-title":"Adolescent girls with polycystic ovary syndrome have an increased risk of the metabolic syndrome associated with increasing androgen levels independent of obesity and insulin resistance","volume":"91","author":"Coviello","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib233","first-page":"4","article-title":"Etiology of hirsutism: is there a correlation between menstrual irregularity, body mass index and severity of hirsutism with the cause?","volume":"20","author":"Farid-ur-Rehman","year":"2010","journal-title":"J Pakistan Assoc Dermatol"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib234","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1111\/j.1471-0528.2006.00973.x","article-title":"The central issue? Visceral fat mass is a good marker of insulin resistance and metabolic disturbance in women with polycystic ovary syndrome","volume":"113","author":"Lord","year":"2006","journal-title":"BJOG"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib235","doi-asserted-by":"crossref","first-page":"323","DOI":"10.2478\/v10042-009-0032-0","article-title":"Leptin concentrations in patients with polycystic ovary syndrome before and after metformin treatment depending on insulin resistance, body mass index and androgen concentrations\u2014introductory report","volume":"47","author":"Marciniak","year":"2009","journal-title":"Folia Histochem Cytobiol"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib236","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1093\/humrep\/deq028","article-title":"Appropriate BMI levels for PCOS patients in Southern China","volume":"25","author":"Chen","year":"2010","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib237","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.ijgo.2009.09.021","article-title":"Association of biochemical hyperandrogenism with type 2 diabetes and obesity in Chinese women with polycystic ovary syndrome","volume":"108","author":"Zhao","year":"2010","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib238","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1111\/j.1365-2265.1994.tb02577.x","article-title":"Serum lipoprotein lipid profile in women with the polycystic ovary syndrome: relation to anthropometric, endocrine and metabolic variables","volume":"41","author":"Holte","year":"1994","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib239","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1093\/humrep\/16.6.1255","article-title":"Body composition characteristics and body fat distribution in lean women with polycystic ovary syndrome","volume":"16","author":"Kirchengast","year":"2001","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib240","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.ejogrb.2005.11.012","article-title":"The association of serum androgens and insulin resistance with fat distribution in polycystic ovary syndrome","volume":"126","author":"Yucel","year":"2006","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib241","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/0026-0495(94)90118-X","article-title":"Body fat distribution has weight-independent effects on clinical, hormonal, and metabolic features of women with polycystic ovary syndrome","volume":"43","author":"Pasquali","year":"1994","journal-title":"Metabolism"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib242","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/0029-7844(95)00250-U","article-title":"Body fat distribution in women with polycystic ovary syndrome","volume":"86","author":"Douchi","year":"1995","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib243","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/j.1749-6632.1991.tb37915.x","article-title":"Obesity and polycystic ovary syndrome","volume":"626","author":"Franks","year":"1991","journal-title":"Ann NY Acad Sci"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib244","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1111\/j.1471-0528.1992.tb14470.x","article-title":"Association of moderate obesity with a poor pregnancy outcome in women with polycystic ovary syndrome treated with low dose gonadotrophin","volume":"99","author":"Hamilton-Fairley","year":"1992","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib245","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1093\/humrep\/16.5.940","article-title":"Does obesity diminish the positive effect of oral contraceptive treatment on hyperandrogenism in women with polycystic ovarian syndrome?","volume":"16","author":"Cibula","year":"2001","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib246","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.ijgo.2009.06.003","article-title":"Effect of body mass index on clinical manifestations in patients with polycystic ovary syndrome","volume":"107","author":"Tamimi","year":"2009","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib247","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/S0015-0282(99)00184-3","article-title":"Insulin, androgens, and obesity in women with and without polycystic ovary syndrome: a heterogeneous group of disorders","volume":"72","author":"Acien","year":"1999","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib248","doi-asserted-by":"crossref","first-page":"E238","DOI":"10.1152\/ajpendo.90684.2008","article-title":"Anti-m\u00fcllerian hormone levels reflect severity of PCOS but are negatively influenced by obesity: relationship with increased luteinizing hormone levels","volume":"296","author":"Piouka","year":"2009","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib249","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1530\/EJE-07-0143","article-title":"Retinol-binding protein 4 levels are elevated in polycystic ovary syndrome women with obesity and impaired glucose metabolism","volume":"157","author":"Hahn","year":"2007","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib250","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/09513590903015528","article-title":"Central-to-peripheral fat ratio, but not peripheral body fat, is related to insulin resistance and androgen markers in polycystic ovary syndrome","author":"Godoy-Matos","year":"2009","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib251","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1507\/endocrj.48.685","article-title":"Relationships among serum testosterone levels, body fat and muscle mass distribution in women with polycystic ovary syndrome","volume":"48","author":"Douchi","year":"2001","journal-title":"Endocr J"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib252","first-page":"202","article-title":"Insulin resistance and upper-body obesity in polycystic ovary syndrome","volume":"11","author":"Al-Bayatti","year":"2006","journal-title":"Middle East Fertil Soc J"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib253","doi-asserted-by":"crossref","first-page":"2500","DOI":"10.1210\/jc.2006-2725","article-title":"Abdominal fat quantity and distribution in women with polycystic ovary syndrome and extent of its relation to insulin resistance","volume":"92","author":"Carmina","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib254","doi-asserted-by":"crossref","unstructured":"Cascella T, Palomba S, De Sio I, Manguso F, Giallauria F, De Simone B, et\u00a0al. Visceral fat is associated with cardiovascular risk in women with polycystic ovary syndrome. Hum Reprod 2008;23:153\u20139.","DOI":"10.1093\/humrep\/dem356"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib255","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/j.1365-2265.1992.tb02909.x","article-title":"Improvement in endocrine and ovarian function during dietary treatment of obese women with polycystic ovary syndrome","volume":"36","author":"Kiddy","year":"1992","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib256","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1093\/humrep\/13.6.1502","article-title":"Weight loss in obese infertile women results in improvement in reproductive outcome for all forms of fertility treatment","volume":"13","author":"Clark","year":"1998","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib257","first-page":"CD007506","article-title":"Lifestyle changes in women with polycystic ovary syndrome","volume":"2","author":"Moran","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib258","first-page":"774","article-title":"Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis","volume":"18","author":"Dunaif","year":"1997","journal-title":"Endocr Rev"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib259","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1210\/jcem-65-3-499","article-title":"Characterization of groups of hyperandrogenic women with acanthosis nigricans, impaired glucose tolerance, and\/or hyperinsulinemia","volume":"65","author":"Dunaif","year":"1987","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib260","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/j.1365-2265.1993.tb02376.x","article-title":"The relationship of insulin insensitivity to menstrual pattern in women with hyperandrogenism and polycystic ovaries","volume":"39","author":"Robinson","year":"1993","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib261","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1093\/humrep\/den433","article-title":"Indicators for metabolic disturbances in anovulatory women with polycystic ovary syndrome diagnosed according to the Rotterdam consensus criteria","volume":"24","author":"Goverde","year":"2009","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib262","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1093\/humupd\/dmp008","article-title":"Metabolic features of the reproductive phenotypes of polycystic ovary syndrome","volume":"15","author":"Moran","year":"2009","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib263","doi-asserted-by":"crossref","first-page":"2571","DOI":"10.1210\/jc.2004-0219","article-title":"Polycystic ovaries are common in women with hyperandrogenic chronic anovulation but do not predict metabolic or reproductive phenotype","volume":"90","author":"Legro","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib264","doi-asserted-by":"crossref","first-page":"3236","DOI":"10.1210\/jc.2004-1843","article-title":"Changes in glucose tolerance over time in women with polycystic ovary syndrome: a controlled study","volume":"90","author":"Legro","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib265","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/j.fertnstert.2009.04.021","article-title":"Not all women diagnosed with PCOS share the same cardiovascular risk profiles","volume":"94","author":"Jovanovic","year":"2010","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib266","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/sj.ejhg.5201802","article-title":"Relationship between E23K (an established type II diabetes-susceptibility variant within KCNJ11), polycystic ovary syndrome and androgen levels","volume":"15","author":"Barber","year":"2007","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib267","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.tem.2003.08.002","article-title":"Polycystic ovary syndrome: syndrome XX?","volume":"14","author":"Sam","year":"2003","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib268","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1172\/JCI118064","article-title":"Insulin secretory defects in polycystic ovary syndrome: relationship to insulin sensitivity and family history of non-insulin-dependent diabetes mellitus","volume":"96","author":"Ehrmann","year":"1995","journal-title":"J Clin Invest"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib269","doi-asserted-by":"crossref","first-page":"2617","DOI":"10.1210\/jc.2008-1664","article-title":"Evidence for association between polycystic ovary syndrome (PCOS) and TCF7L2 and glucose intolerance in women with PCOS and TCF7L2","volume":"94","author":"Biyasheva","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib270","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.2337\/db07-9903","article-title":"Orchestration of glucose homeostasis: from a small acorn to the California oak","volume":"56","author":"Bergman","year":"2007","journal-title":"Diabetes"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib271","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1093\/ajcn\/4.1.20","article-title":"The degree of masculine differentiation of obesities: a factor determining predisposition to diabetes, atherosclerosis, gout, and uric calculous disease","volume":"4","author":"Vague","year":"1956","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib272","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1210\/jcem-70-2-473","article-title":"Androgen-estrogen metabolism in women with upper body versus lower body\u00a0obesity","volume":"70","author":"Kirschner","year":"1990","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib273","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1016\/j.fertnstert.2005.10.054","article-title":"Obesity and androgens: facts and perspectives","volume":"85","author":"Pasquali","year":"2006","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib274","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/S0015-0282(98)00098-3","article-title":"Pituitary desensitization to gonadotropin-releasing hormone increases abdominal adiposity in hyperandrogenic anovulatory women","volume":"70","author":"Dumesic","year":"1998","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib275","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1007\/s00125-008-1028-6","article-title":"Association of variants in the fat mass and obesity associated (FTO) gene with polycystic ovary syndrome","volume":"51","author":"Barber","year":"2008","journal-title":"Diabetologia"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib276","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1210\/jc.2007-2117","article-title":"Global adiposity rather than abnormal regional fat distribution characterizes women with polycystic ovary syndrome","volume":"93","author":"Barber","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib277","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1210\/jc.2002-021573","article-title":"Mechanisms behind lipolytic catecholamine resistance of subcutaneous fat cells in the polycystic ovarian syndrome","volume":"88","author":"Faulds","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib278","doi-asserted-by":"crossref","first-page":"484","DOI":"10.2337\/diabetes.51.2.484","article-title":"A unique defect in the regulation of visceral fat cell lipolysis in the polycystic ovary syndrome as an early link to insulin resistance","volume":"51","author":"Ek","year":"2002","journal-title":"Diabetes"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib279","doi-asserted-by":"crossref","first-page":"14956","DOI":"10.1073\/pnas.95.25.14956","article-title":"Evidence for a genetic basis for hyperandrogenemia in polycystic ovary syndrome","volume":"95","author":"Legro","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib280","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1210\/jc.2005-1804","article-title":"Commentary: polycystic ovary syndrome: a syndrome of ovarian hypersensitivity to insulin?","volume":"91","author":"Baillargeon","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib281","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1097\/00132577-200512000-00018","article-title":"Diagnosis and management of the metabolic syndrome: an American Heart Association\/National Heart, Lung, and Blood Institute scientific statement: executive summary","volume":"4","author":"Grundy","year":"2005","journal-title":"Crit Pathw Cardiol"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib282","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1210\/jc.2004-1045","article-title":"Prevalence and characteristics of the metabolic syndrome in women with polycystic ovary syndrome","volume":"90","author":"Apridonidze","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib283","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1016\/S0015-0282(03)00347-9","article-title":"The androgenic sex hormone profile is an essential feature of metabolic syndrome in premenopausal women: a controlled community-based study","volume":"79","author":"Korhonen","year":"2003","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib284","doi-asserted-by":"crossref","first-page":"3970","DOI":"10.1210\/jc.2005-2250","article-title":"Treatment with flutamide, metformin, and their combination added to a hypocaloric diet in overweight-obese women with polycystic ovary syndrome: a randomized, 12-month, placebo-controlled study","volume":"91","author":"Gambineri","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib285","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1111\/j.1365-2265.1992.tb02262.x","article-title":"Postprandial thermogenesis is reduced in polycystic ovary syndrome and is associated with increased insulin resistance","volume":"36","author":"Robinson","year":"1992","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib286","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1210\/rp.56.1.295","article-title":"Insulin resistance in polycystic ovary syndrome: progress and paradoxes","volume":"56","author":"Venkatesan","year":"2001","journal-title":"Recent Prog Horm Res"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib287","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1111\/j.1365-2265.2007.02764.x","article-title":"Metabolic characteristics of women with polycystic ovaries and oligo-amenorrhoea but normal androgen levels: implications for the management of polycystic ovary syndrome","volume":"66","author":"Barber","year":"2007","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib288","doi-asserted-by":"crossref","first-page":"3922","DOI":"10.1210\/jc.2006-1054","article-title":"Oligoanovulation with polycystic ovaries but not overt hyperandrogenism","volume":"91","author":"Dewailly","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib289","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1046\/j.1365-2265.1996.674495.x","article-title":"Dyslipidaemia is associated with insulin resistance in women with polycystic ovaries","volume":"44","author":"Robinson","year":"1996","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib290","doi-asserted-by":"crossref","first-page":"141","DOI":"10.2337\/diacare.22.1.141","article-title":"Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome","volume":"22","author":"Ehrmann","year":"1999","journal-title":"Diabetes Care"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib291","first-page":"165","article-title":"Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women","volume":"84","author":"Legro","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib292","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1001\/jama.286.19.2421","article-title":"Long or highly irregular menstrual cycles as a marker for risk of type 2 diabetes mellitus","volume":"286","author":"Solomon","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib293","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1080\/1464727002000198781","article-title":"Long-term consequences of polycystic ovary syndrome: results of a 31 year follow-up study","volume":"3","author":"Wild","year":"2000","journal-title":"Hum Fertil (Camb)"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib294","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1046\/j.1365-2265.2000.01000.x","article-title":"Cardiovascular disease in women with polycystic ovary syndrome at long-term follow-up: a retrospective cohort study","volume":"52","author":"Wild","year":"2000","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib295","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1093\/humrep\/16.9.1995","article-title":"Relative risk of conversion from normoglycaemia to impaired glucose tolerance or non-insulin dependent diabetes mellitus in polycystic ovarian syndrome","volume":"16","author":"Norman","year":"2001","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib296","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1210\/jcem.87.5.8513","article-title":"Insulin resistance in the sisters of women with polycystic ovary syndrome: association with hyperandrogenemia rather than menstrual irregularity","volume":"87","author":"Legro","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib297","doi-asserted-by":"crossref","first-page":"3396","DOI":"10.1210\/jc.2008-0369","article-title":"Ovarian morphology is a marker of heritable biochemical traits in sisters with polycystic ovaries","volume":"93","author":"Franks","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib298","doi-asserted-by":"crossref","first-page":"6364","DOI":"10.1210\/jc.2005-1490","article-title":"The polycystic ovary syndrome associated with morbid obesity may resolve after weight loss induced by bariatric surgery","volume":"90","author":"Escobar-Morreale","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib299","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/S0140-6736(04)17018-9","article-title":"Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study","volume":"364","author":"Yusuf","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib300","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.fertnstert.2005.12.054","article-title":"Difference in dietary intake between women with polycystic ovary syndrome and healthy controls","volume":"86","author":"Douglas","year":"2006","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib301","doi-asserted-by":"crossref","first-page":"83","DOI":"10.3945\/ajcn.2010.29261","article-title":"Effect of a low glycemic index compared with a conventional healthy diet on polycystic ovary syndrome","volume":"92","author":"Marsh","year":"2010","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib302","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/j.fertnstert.2008.01.035","article-title":"Comparison of hormonal and metabolic markers after a high-fat, Western meal versus a low-fat, high-fiber meal in women with polycystic ovary syndrome","volume":"91","author":"Katcher","year":"2009","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib303","doi-asserted-by":"crossref","first-page":"475","DOI":"10.4158\/EP09083.RAR","article-title":"Polycystic ovary syndrome, depression, and affective disorders","volume":"15","author":"Bishop","year":"2009","journal-title":"Endocr Pract"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib304","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1097\/AOG.0b013e318202b0a4","article-title":"Increased risk for abnormal depression scores in women with polycystic ovary syndrome: a systematic review and meta-analysis","volume":"117","author":"Dokras","year":"2011","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib305","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1046\/j.1365-2265.2001.01228.x","article-title":"Lipids and lipoprotein subfractions in women with PCOS: relationship to metabolic and endocrine parameters","volume":"54","author":"Pirwany","year":"2001","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib306","first-page":"1175","article-title":"Increased prevalence of obstructive sleep apnea syndrome in obese women with polycystic ovary syndrome","volume":"86","author":"Fogel","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib307","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0015-0282(16)53699-1","article-title":"Clinical signs of androgen excess as risk factors for coronary artery disease","volume":"54","author":"Wild","year":"1990","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib308","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1016\/j.fertnstert.2010.02.015","article-title":"Variation in metabolic and cardiovascular risk in women with different polycystic ovary syndrome phenotypes","volume":"94","author":"Wiltgen","year":"2010","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib309","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/oby.2009.297","article-title":"Optimal waist circumference for prediction of metabolic syndrome in young Korean women with polycystic ovary syndrome","volume":"18","author":"Oh","year":"2010","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib310","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/j.fertnstert.2010.12.027","article-title":"Lipid levels in polycystic ovary syndrome: systematic review and meta-analysis","volume":"95","author":"Wild","year":"2011","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib311","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1161\/01.CIR.0000080897.52664.94","article-title":"Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study","volume":"108","author":"Sattar","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib312","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/S0002-9378(11)90605-X","article-title":"Lipid and apolipoprotein abnormalities in hirsute women. I. The association with insulin resistance","volume":"166","author":"Wild","year":"1992","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib313","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1210\/jc.2006-1705","article-title":"Atherogenic lipoprotein phenotype and low-density lipoproteins size and subclasses in women with polycystic ovary syndrome","volume":"92","author":"Berneis","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib314","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1155\/2009\/465203","article-title":"Clinical significance of inflammatory markers in polycystic ovary syndrome: their relationship to insulin resistance and body mass index","volume":"26","author":"Samy","year":"2009","journal-title":"Dis Markers"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib315","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1042\/CS20080218","article-title":"A comprehensive assessment of endothelial function in overweight women with and without polycystic ovary syndrome","volume":"116","author":"Moran","year":"2009","journal-title":"Clin Sci (Lond)"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib316","doi-asserted-by":"crossref","DOI":"10.1111\/j.1365-2265.2008.03506.x","article-title":"Increased arterial stiffness in nonobese women with polycystic ovary syndrome (PCOS) without comorbidities: one more characteristic inherent to the syndrome?","volume":"71","author":"Soares","year":"2009","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib317","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1097\/GME.0b013e31802cc7ab","article-title":"Searching for polycystic ovary syndrome in postmenopausal women: evidence of a dose-effect association with prevalent cardiovascular disease","volume":"14","author":"Krentz","year":"2007","journal-title":"Menopause"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib318","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.metabol.2008.02.012","article-title":"Relationship between endogenous testosterone and cardiovascular risk in early postmenopausal women","volume":"57","author":"Maturana","year":"2008","journal-title":"Metabolism"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib319","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1016\/j.fertnstert.2004.11.070","article-title":"Prevalence of insulin resistance in the polycystic ovary syndrome using the homeostasis model assessment","volume":"83","author":"DeUgarte","year":"2005","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib320","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.2337\/diab.38.9.1165","article-title":"Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome","volume":"38","author":"Dunaif","year":"1989","journal-title":"Diabetes"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib321","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1210\/jcem.87.3.8305","article-title":"Screening for abnormal glucose tolerance in adolescents with polycystic ovary syndrome","volume":"87","author":"Palmert","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib322","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s11892-006-0056-1","article-title":"Risk of T2DM and impaired fasting glucose among PCOS subjects: results of an 8-year follow-up","volume":"6","author":"Boudreaux","year":"2006","journal-title":"Curr Diab Rep"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib323","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1016\/j.fertnstert.2006.05.038","article-title":"Obesity and insulin resistance but not hyperandrogenism mediates vascular dysfunction in women with polycystic ovary syndrome","volume":"86","author":"Dokras","year":"2006","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib324","doi-asserted-by":"crossref","first-page":"4566","DOI":"10.1210\/jc.2010-0868","article-title":"Greater arterial stiffness in polycystic ovary syndrome (PCOS) is an obesity\u2014but not a PCOS-associated phenomenon","volume":"95","author":"Ketel","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib325","doi-asserted-by":"crossref","first-page":"32","DOI":"10.7326\/0003-4819-126-1-199701010-00005","article-title":"Association between polycystic ovaries and extent of coronary artery disease in women having cardiac catheterization","volume":"126","author":"Birdsall","year":"1997","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib326","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1161\/01.ATV.20.11.2414","article-title":"Evidence for association between polycystic ovary syndrome and premature carotid atherosclerosis in middle-aged women","volume":"20","author":"Talbott","year":"2000","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib327","doi-asserted-by":"crossref","first-page":"3197","DOI":"10.1093\/humrep\/dem324","article-title":"Androgen excess is associated with the increased carotid intima-media thickness observed in young women with polycystic ovary syndrome","volume":"22","author":"Luque-Ramirez","year":"2007","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib328","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1210\/jc.2003-030334","article-title":"Prevalence and predictors of coronary artery calcification in women with polycystic ovary syndrome","volume":"88","author":"Christian","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib329","doi-asserted-by":"crossref","first-page":"5454","DOI":"10.1210\/jc.2003-032237","article-title":"Evidence for an association between metabolic cardiovascular syndrome and coronary and aortic calcification among women with polycystic ovary syndrome","volume":"89","author":"Talbott","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib330","doi-asserted-by":"crossref","first-page":"453","DOI":"10.2147\/VHRM.S1452","article-title":"Is there an independent effect of polycystic ovary syndrome (PCOS) and menopause on the prevalence of subclinical atherosclerosis in middle aged women?","volume":"4","author":"Talbott","year":"2008","journal-title":"Vasc Health Risk Manag"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib331","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1093\/humrep\/16.3.556","article-title":"Prevalence of diabetes mellitus, hypertension and cardiac complaints in a follow-up study of a Dutch PCOS population","volume":"16","author":"Elting","year":"2001","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib332","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1093\/humrep\/15.4.785","article-title":"Increased risk of non-insulin dependent diabetes mellitus, arterial hypertension and coronary artery disease in perimenopausal women with a history of the polycystic ovary syndrome","volume":"15","author":"Cibula","year":"2000","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib333","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S0895-4356(98)00035-3","article-title":"Mortality of women with polycystic ovary syndrome at long-term follow-up","volume":"51","author":"Pierpoint","year":"1998","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib334","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1210\/jc.2007-0425","volume":"93","author":"Shaw","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib335","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1590\/S0004-27302006000500008","article-title":"Menstrual cycle irregularity as a marker of cardiovascular risk factors at postmenopausal years [article in Portuguese]","volume":"50","author":"Azevedo","year":"2006","journal-title":"Arq Bras Endocrinol Metabol"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib336","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/S1472-6483(10)60175-7","article-title":"Polycystic ovary syndrome and the risk of gynaecological cancer: a systematic review","volume":"19","author":"Chittenden","year":"2009","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib337","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/0029-7844(96)00226-8","article-title":"Epithelial ovarian cancer risk among women with polycystic ovary syndrome","volume":"88","author":"Schildkraut","year":"1996","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib338","first-page":"403","article-title":"Chronic anovulation syndrome and associated neoplasia","volume":"61","author":"Coulam","year":"1983","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib339","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1016\/S0140-6736(03)13409-5","article-title":"Polycystic ovary syndrome and endometrial carcinoma","volume":"361","author":"Hardiman","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib340","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/0090-8258(79)90111-2","article-title":"The woman at risk for developing ovarian cancer","volume":"7","author":"McGowan","year":"1979","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib341","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1056\/NEJM199409223311204","article-title":"Ovarian tumors in a cohort of infertile women","volume":"331","author":"Rossing","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib342","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1097\/00001648-199211000-00005","article-title":"Characteristics relating to ovarian cancer risk: collaborative analysis of 12 U.S. case-control studies. VI. Nonepithelial cancers among adults. Collaborative Ovarian Cancer Group","volume":"3","author":"Horn-Ross","year":"1992","journal-title":"Epidemiology"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib343","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1093\/oxfordjournals.aje.a116427","article-title":"Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies. II. Invasive epithelial ovarian cancers in white women. Collaborative Ovarian Cancer Group","volume":"136","author":"Whittemore","year":"1992","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib344","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1093\/oxfordjournals.aje.a116428","article-title":"Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies. III. Epithelial tumors of low malignant potential in white women. Collaborative Ovarian Cancer Group","volume":"136","author":"Harris","year":"1992","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib345","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/S0140-6736(03)14410-8","article-title":"Formation and early development of follicles in the polycystic ovary","volume":"362","author":"Webber","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib346","doi-asserted-by":"crossref","unstructured":"Hudecova M, Holte J, Olovsson M, Sundstrom Poromea I. Long-term follow-up of patients with polycystic ovary syndrome: reproductive outcome and ovarian reserve. Hum Reprod 2009;24:1176\u201383.","DOI":"10.1093\/humrep\/den482"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib347","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1093\/humrep\/deh850","article-title":"Serum anti-mullerian hormone levels remain high until late reproductive age and decrease during metformin therapy in women with polycystic ovary syndrome","volume":"20","author":"Piltonen","year":"2005","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib348","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1093\/humrep\/deh373","article-title":"Changes in anti-m\u00fcllerian hormone serum concentrations over time suggest delayed ovarian ageing in normogonadotrophic anovulatory infertility","volume":"19","author":"Mulders","year":"2004","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib349","doi-asserted-by":"crossref","first-page":"3847","DOI":"10.1210\/jc.2005-0212","article-title":"Androgen levels in adult females: changes with age, menopause, and oophorectomy","volume":"90","author":"Davison","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib350","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/S0015-0282(99)00641-X","article-title":"Serum testosterone levels decrease in middle age in women with the polycystic ovary syndrome","volume":"73","author":"Winters","year":"2000","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib351","first-page":"2361","article-title":"Predictors of patients remaining anovulatory during clomiphene citrate induction of ovulation in normogonadotropic oligoamenorrheic infertility","volume":"83","author":"Imani","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib352","doi-asserted-by":"crossref","first-page":"3458","DOI":"10.1210\/jc.2009-0545","article-title":"Predictors of pregnancy in women with polycystic ovary syndrome","volume":"94","author":"Rausch","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib353","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1046\/j.1365-2265.1996.676498.x","article-title":"Polycystic ovaries in pre and post-menopausal women","volume":"44","author":"Birdsall","year":"1996","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib354","doi-asserted-by":"crossref","first-page":"5305","DOI":"10.1210\/jc.2010-1123","article-title":"Total testosterone assays in women with polycystic ovary syndrome: precision and correlation with hirsutism","volume":"95","author":"Legro","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib355","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1080\/13697130801972304","article-title":"Management of polycystic ovary syndrome in postmenopausal women: a medical black hole","volume":"11","author":"Fenton","year":"2008","journal-title":"Climacteric"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib356","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1093\/humrep\/deq149","article-title":"Augmentation of cortical bone mineral density in women with polycystic ovary syndrome: a peripheral quantitative computed tomography (pQCT) study","volume":"25","author":"Kassanos","year":"2010","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib357","doi-asserted-by":"crossref","first-page":"3496","DOI":"10.1210\/jcem.85.10.6902","article-title":"Clinical review 116: bone mineral density, androgens, and the polycystic ovary: the complex and controversial issue of androgenic influence in female bone","volume":"85","author":"Zborowski","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib358","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/S0895-4356(98)00010-9","article-title":"Adverse lipid and coronary heart disease risk profiles in young women with polycystic ovary syndrome: results of a case-control study","volume":"51","author":"Talbott","year":"1998","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib359","first-page":"517","article-title":"Polycystic ovary syndrome is associated with obstructive sleep apnea and daytime sleepiness: role of insulin resistance","volume":"86","author":"Vgontzas","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib360","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1067\/mjd.2000.107953","article-title":"Lack of efficacy of finasteride in postmenopausal women with androgenetic alopecia","volume":"43","author":"Price","year":"2000","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib361","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.4158\/EP.14.9.1084","article-title":"Risk of cardiovascular events in mothers of women with polycystic ovary syndrome","volume":"14","author":"Cheang","year":"2008","journal-title":"Endocr Pract"},{"key":"10.1016\/j.fertnstert.2011.09.024_bib362","doi-asserted-by":"crossref","unstructured":"Taylor MC, Reema KA, Kunselman AR, Stetter CM, Dunaif A, Legro RS. Evidence for increased cardiovascular events in the fathers but not mothers of women with polycystic ovary syndrome. Hum Reprod. Published online April 19, 2011.","DOI":"10.1093\/humrep\/der101"}],"container-title":["Fertility and Sterility"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028211025520?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028211025520?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T06:12:10Z","timestamp":1762150330000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0015028211025520"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1]]},"references-count":362,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,1]]}},"alternative-id":["S0015028211025520"],"URL":"https:\/\/doi.org\/10.1016\/j.fertnstert.2011.09.024","relation":{},"ISSN":["0015-0282"],"issn-type":[{"value":"0015-0282","type":"print"}],"subject":[],"published":{"date-parts":[[2012,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Consensus on women\u2019s health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE\/ASRM-Sponsored 3rd PCOS Consensus Workshop Group","name":"articletitle","label":"Article Title"},{"value":"Fertility and Sterility","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.fertnstert.2011.09.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}